Search

You searched for "imaging"

2763 results found

Topical insulin for neurotrophic ulcers

1 February 2018 | | EYE - Cornea, EYE - General
This retrospective case series described the use of topical insulin drops as an aid in treatment of refractory neurotrophic corneal ulceration in six patients. Insulin drops were prepared under sterile conditions from standard insulin preparations mixed with artificial tears containing...

Acanthamoeba keratitis

1 October 2021 | | EYE - Cornea, EYE - General
This is a retrospective case series on medical records and corneal photographs of 40 eyes of 35 patients with acanthamoeba keratitis (AK, culture positive or with histopathological diagnosis). The mean age of onset was 30 ±15 years (younger in females)....

New Treatments in Noninfectious Uveitis

1 December 2013 | | EYE - General, EYE - Vitreo-Retinal
As a specialist registrar training in Aberdeen there were two important lessons I learned which have proved to be invaluable over the years for two very different reasons. The first lesson learned was to never underestimate the wind chill factor...

Report: UKEGS 2024

29 October 2024 | UKEGS, 2024, conferences, meetings, events, industry, glaucoma, Glaucoma UK, Nishani Amerasinghe, Andrew Tatham
It was an incredible experience heading down to UKEGS 2024 earlier this month in Southampton. The entire Glaucoma UK team, along with the UKEGS overseeing panel Nishani Amerasinghe, Andrew Tatham, Professir Anthony King and Professor Gus Gazzard, took great care...

The expanding role of the optometrist

5 December 2025 | | EYE - General
Eyecare in the UK has seen significant changes in recent years, with new models of care, technological advancements and an increased emphasis on primary eyecare in some UK nations. Crucially, an ageing population demographic is set to escalate further both...

Antibiotic prophylaxis after intravitreal injections

1 June 2014 | | EYE - General
The use of topical antibiotics as prophylaxis after intravitreal injections is a contentious issue, especially now with increasing use of intravitreal anti-VEGF agents. In the Wills Eye Institute, prior to May 2011, all patients undergoing intravitreal injections in the office...

Pathway innovations to address cataract services post-COVID-19

1 June 2022 | | EYE - Cataract, EYE - Refractive
Background The demand for cataract services prior to the COVID-19 pandemic was already recognised to be high and growing - in the face of an ageing population and reduced surgical thresholds. When added to the growth in demand for ophthalmic...

What's trending Feb/Mar 2025

4 February 2025 | | EYE - Cornea, EYE - Neuro-ophthalmology, EYE - Paediatrics, EYE - Vitreo-Retinal
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #ChrisMcCausland #StrictlyWinner “I hope that anybody out there that doesn’t know someone who is blind now has higher expectations of what...

SPOKE launches Project Four Supervision Guidance

31 January 2024 | optometry, optometrist, guidance, GOC, AHP, allied health professions
The Sector Partnership for Optical Knowledge and Education (SPOKE) has published the output of its fourth project.

Lothian Optometry Teach and Treat Clinic

1 December 2013 |
The Lothian Optometry Teach and Treat (LOTT) Clinic is a supervised training clinic for community optometrists with an interest in managing patients with acute eye pathology, normally managed in the hospital setting. LOTT, which is the first clinic of its...

Q&A: Mr Goel and Mr Loomba on alcohol delamination and phototherapeutic keratectomy (PTK) for the treatment of recurrent corneal erosion syndrome

14 June 2023 | | EYE - Cornea
Recurrent corneal erosion syndrome is a common, recurrent condition caused by abnormal epithelial adhesion to the underlying basal lamina. Spontaneous breakdown of the corneal epithelium can lead to the sudden onset of ocular pain, blurred vision, tearing and photophobia, typically...

Vabysmo receives NICE approval

27 September 2024 | Awards, Conferences & Anniversaries, Company Profiles, Research & Development
The National Institute for Health and Care Excellence (NICE) has recently approved Vabysmo▼(faricimab) for treating adults with visual impairment due to macular oedema secondary to branch and central retinal vein occlusion (BRVO and CRVO). The NICE approval of Vabysmo was...